Part of the multiple myeloma-associated microvessels is functionally connected to the systemic circulation: A study in the murine 5T33MM model

Virchows Archiv

Volumn 445, Issue 4, 2004, Pages 389-395

  De Raeve, Hendrik R ^a   Asosingh, Kewal ^b   Wisse, Eddie ^b   Van Camp, Ben ^b   Van Marck, Eric ^a   Vanderkerken, Karin ^b  

^a UNIVERSITY OF ANTWERP   (Belgium)

^b VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

Author keywords

Angiogenesis; Delivery capacity; Ferritin; Microvessel density; Multiple myeloma

Indexed keywords

FERRITIN;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW; CARCINOGENESIS; CONTROLLED STUDY; METASTASIS; MICROVASCULATURE; MOUSE; MULTIPLE MYELOMA; MYELOMA; NONHUMAN; NUTRIENT SUPPLY; PRIORITY JOURNAL; PROGNOSIS; SYSTEMIC CIRCULATION; TUMOR BLOOD FLOW; TUMOR GROWTH; TUMOR VASCULARIZATION;

ANIMALS; ANTIGENS, CD31; FERRITINS; MICE; MICE, INBRED C57BL; MULTIPLE MYELOMA; NEOVASCULARIZATION, PATHOLOGIC;

EID: 8744306911     PISSN: 09456317     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00428-004-1064-7     Document Type: Article

References (22)

1. Asosingh K, Gunthert U, Bakkus MHC, De Raeve H, Goes E, Van Riet I, Van Camp B, Vanderkerken K (2000) In vivo induction of insulin-like growth factor-I receptor and CD44v6 confers homing and adhesion to murine multiple myeloma cells. Cancer Res 60:3096-3104
2. Asosingh K, De Raeve H, Van Riet I, Van Camp B, Vanderkerken K (2003) Multiple myeloma tumor progression in the 5T2MM murine model is a multistage and dynamic process of differentiation, proliferation, invasion, and apoptosis. Blood 101:3136-3141
3. Asosingh K, De Raeve H, Menu E, Van Riet I, Van Marck E, Van Camp B, Vanderkerken K (2004) Angiogenic switch during 5T2MM murine myeloma tumorigenesis; role of CD45 heterogeneity. Blood 103:3131-3137
4. Baish JW, Gazit Y, Berk DA, Nozue M, Baxter LT, Jain RK (1996) Role of Tumor vascular architecture in nutrient and drug delivery: an invasion percolation-based network model. Microvasc Res 51:327-246
5. Baish JW, Jain RK (2000) Fractals and cancer. Cancer Res 60:3683-3688
6. Bellamy WT, Richter L, Frutiger Y, Grogan TM (1999) Expression of vascular endothelial growth factor and its receptors in hematopoietic malignancies. Cancer Res 59:728-733
7. Dankbar B, Padro T, Leo R, Feldmann B, Kropff M, Mesters RM, Serve H, Berdel WE, Kienast J (2000) Vascular endothelial growth factor and interleukin-6 in paracrine tumor-stromal cell interactions in multiple myeloma. Blood 95:2630-2636
8. De Raeve HR, Vermeulen PB, Vanderkerken K, Harris AL, Van Marck E (2004) Microvessel density, endothelial cell proliferation and carbonic anhydrase IX expression in haematological malignancies, bone marrow metastases and monoclonal gammopathy of undetermined significance. Virchows Arch (Published online 28 May 2004)
9. Eskey CJ, Koretsky AP, Domach MM, Jain RK (1992) H-Nuclear magnetic resonance imaging of tumour blood flow: spatial and temporal heterogeneity in tissue-isolated mammary adenocarcinoma. Cancer Res 52:6010-6019
10. Feng D, Nagy JA, Hipp J, Dvorak HF, Dvorak AM (1996) Vesiculo-vacuolar organelles and the regulation of venule permeability to macromolecules by vascular permeability factor, histamine, and serotonin. J Exp Med 183:1981-1986
11. Jain RK (1988) Determinants of tumor blood flow: a review. Cancer Res 48:2641-2658
12. Kohn S, Nagy JA, Dvorak HF, Dvorak AM (1992) Pathways of macromolecular tracer transport across venules and small veins. Lab Invest 67:596-607
13. Mollica F, Jain RK, Netti PA (2003) A model for temporal heterogeneities of tumor blood flow. Microvascular Res 65:56-60
14. Radl J, Croese JW, Zurcher C, Van den Enden-Vieveen MH, de Leeuw AM (1988) Animal model of human disease. Multiple myeloma. Am J Pathol 132:593-597
15. Rajkumar SV, Leong T, Roche PC, Fonseca R, Dispenzieri A, Lacy Q, Lust JA, Witzig TE, Kyle RA, Gertz MA, Greipp PR (2000) Prognostic value of bone marrow angiogenesis in multiple myeloma. Clin Cancer Res 6:3111-3116
16. Vacca A, Ribatti D, Roncali L, Ranieri G, Serio G, Silvestris F, Dammacco F (1994) Bone marrow angiogenesis and progression in multiple myeloma. Br J Haematol 87:503-508
17. Vacca A, Ria R, Semeraro F, Merchionne F, Coluccia M, Boccarelli A, Scavelli C, Nico G, Gernone A, Battelli F, Tabilio A, Guidolin D, Petrucci T, Ribatti D, Dammacco F (2003) Endothelial cells in the bone marrow of multiple myeloma. Blood 102:3340-3348
18. Vanderkerken K, De Raeve H, Goes E, Van Meirvenne S, Radl J, Van Riet I, Thielemans K, Van Camp B (1997) Organ involvement and phenotypic adhesion profile of 5T2 and 5T33 myeloma cells in the C57BL/KaLwRij mouse. Br J Cancer 76:451-460
19. Vanderkerken K, Vande Broek I, Eizirik DL, Van Valckenborgh E, Asosingh K, Van Riet I, Van Camp B (2002) Monocyte chemoattractant protein-1 (MCP-1), secreted by bone marrow endothelial cells, induces chemoattraction of 5T multiple myeloma cells. Clin Exp Metastasis 19:87-90
20. Van Valckenborgh E, Bakkus M, Munaut C, Noel A, St Pierre Y, Asosingh K, Van Riet I, Van Camp B, Vanderkerken K (2002) Upregulation of matrix metalloproteinase-9 in murine 5T33 multiple myeloma cells by interaction with bone marrow endothelial cells. Int J Cancer 101:512-518
21. Van Valckenborgh E, De Raeve H, Devy L, Blacher S, Munaut C, Noel A, Van Marck E, Van Riet I, Van Camp B, Vanderkerken K (2002) Murine 5T multiple myeloma cells induce angiogenesis in vitro and in vivo. Br J Cancer 86:796-802
22. Xu JL, Lai R, Kinoshita T, Nakashima N, Nagasaka T (2002) Proliferation, apoptosis, and intratumoural vascularity in multiple myeloma: correlation with the clinical stage and cytological grade. J Clin Pathol 55:530-534